Positive Clinical Breast Cancer Data Presented for NuView’s Molecular…
Next generation PET imaging agent identifies 100% of malignant breast cancer tumors in clinical trial and displays potential to replace many invasive biopsy procedures.
(PRWeb March 13, 2013)
Read the full story at http://www.prweb.com/releases/2013/3/prweb10520654.htmClick here for reuse options!
Copyright 2013 Biotechblog
Comments are closed.